M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Common Shares Outstanding
zł68m
CAGR 3-Years
116%
CAGR 5-Years
59%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Common Shares Outstanding
zł6.2m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
2%
R
Ryvu Therapeutics SA
WSE:RVU
Common Shares Outstanding
zł23.1m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
8%
S
Selvita SA
WSE:SLV
Common Shares Outstanding
zł18.4m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Common Shares Outstanding?
Common Shares Outstanding
68m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Common Shares Outstanding amounts to 68m PLN.

What is Medicofarma Biotech SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
59%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Medicofarma Biotech SA have been 116% over the past three years , 59% over the past five years .

Back to Top